Please use this identifier to cite or link to this item:
http://doi.org/10.25358/openscience-5504Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Roohani, Siyer | - |
| dc.date.accessioned | 2021-01-06T07:37:43Z | - |
| dc.date.available | 2021-01-06T07:37:43Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.uri | https://openscience.ub.uni-mainz.de/handle/20.500.12030/5508 | - |
| dc.language.iso | ger | de |
| dc.rights | InCopyright | * |
| dc.rights.uri | https://rightsstatements.org/page/InC/1.0/?language=en | * |
| dc.subject.ddc | 610 Medizin | de_DE |
| dc.subject.ddc | 610 Medical sciences | en_GB |
| dc.title | Der Endothelinrezeptorantagonist Macitentan verbessert die Isosorbid-5-Mononitrat (ISMN) und Isosorbiddinitrat (ISDN)-induzierte endotheliale Dysfunktion, oxidativen Stress und vaskuläre Inflammation | de_DE |
| dc.type | Dissertation | de |
| dc.identifier.urn | urn:nbn:de:hebis:77-openscience-883688bf-418f-4088-871c-60b82b10c86c3 | - |
| dc.identifier.doi | http://doi.org/10.25358/openscience-5504 | - |
| jgu.type.dinitype | doctoralThesis | en_GB |
| jgu.type.version | Original work | de |
| jgu.type.resource | Text | de |
| jgu.date.accepted | 2020-11-27 | - |
| jgu.description.extent | VI, 131 Blätter | de |
| jgu.organisation.department | FB 04 Medizin | de |
| jgu.organisation.number | 2700 | - |
| jgu.organisation.name | Johannes Gutenberg-Universität Mainz | - |
| jgu.rights.accessrights | openAccess | - |
| jgu.organisation.place | Mainz | - |
| jgu.subject.ddccode | 610 | de |
| jgu.organisation.ror | https://ror.org/023b0x485 | |
| Appears in collections: | JGU-Publikationen | |
Files in This Item:
| File | Description | Size | Format | ||
|---|---|---|---|---|---|
 | roohani_siyer-der_endothelin-20201215174107993.pdf | 4.39 MB | Adobe PDF | View/Open |